Optical imaging developer VisEn Medical has launched its VivoTag 645 fluorescence molecular imaging agent.
The red fluorescent dye is designed for labeling of biomolecules in a broad range of in vitro and in vivo research applications, according to the Bedford, MA-based vendor. VivoTag 645 is VisEn's first offering in the lower-red wavelengths, the company said.
Related Reading
VisEn adds FMT imaging module, touts study results, April 16, 2010
VisEn releases GastroSense, March 26, 2010
VisEn rolls out VivoTag, March 12, 2010
VisEn buys rights to fluorescence agents, January 28, 2010
VisEn launches imaging agent, January 19, 2010
Copyright © 2010 AuntMinnie.com